Stocklytics Platform
Asset logo for symbol VRDN
Viridian Therapeutics
VRDN51
$19.31arrow_drop_down1.83%-$0.36
Asset logo for symbol VRDN
VRDN51

$19.31

arrow_drop_down1.83%
query_stats

VRDN is not a dividend stock

Therefore Dividends subscore should not be taken into consideration

For certain stocks classified as non-dividend stocks, dividend-related data may not be available or applicable. Non-dividend stocks are those where the company does not regularly distribute dividends to its shareholders.

Why No Data?

Non-dividend stocks typically do not offer regular dividend payments. As a result, there might be no dividend-related information or history for such stocks within our database.

Understanding Non-Dividend Stocks

Non-dividend stocks are characterized by companies that reinvest their profits back into the business for expansion, research, development, or other strategic purposes rather than distributing dividends to shareholders.

What This Means for Investors

Investors in non-dividend stocks often focus on capital appreciation, anticipating the value of their shares to increase over time without relying on dividend income.

Stay Updated

While dividend information may not be available for these stocks, other critical financial metrics and analyses are accessible on Stocklytics to aid in informed investment decisions.

Stock Split History (VRDN)

DateSplitMultipleCumulative
Multiple
Nov 13, 20201:15x0.1x0
Nov 7, 20161:15x0.1x0.1

Viridian Therapeutics (VRDN) Dividends & Splits

Viridian Therapeutics, Inc. (VRDN) does not currently offer dividends or have a history of dividend payments. As a biotechnology company focused on the development of novel gene therapies, Viridian prioritizes reinvesting its earnings into research and development efforts to advance its pipeline of innovative treatments. Therefore, investors should not expect any dividend yield or regular dividend payments from Viridian Therapeutics, Inc. (VRDN).
Similarly, Viridian Therapeutics, Inc. (VRDN) has not announced any stock splits to date. A stock split occurs when a company divides its existing shares into multiple shares, potentially lowering the share price. This can make the stock more accessible to a wider range of investors. However, as of now, there have been no stock splits for Viridian Therapeutics, Inc. (VRDN), and no split multiple is applicable.
add Viridian Therapeutics to watchlist

Keep an eye on Viridian Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

Does Viridian Therapeutics (VRDN) stock pay dividends?

No, Viridian Therapeutics (VRDN) does not pay dividends. This could indicate that the company is currently focusing on reinvesting its earnings into growth opportunities rather than distributing them as dividends.
help

When was the last Viridian Therapeutics (VRDN) stock split?

Viridian Therapeutics (VRDN) has undergone 2 total stock splits. The most recent split was a 1:15 split on 2020 Nov 13, leaving the company with 79.21M shares outstanding. Since the company's inception, the cumulative multiple from splits is 0, indicating the overall effect of all splits on the original share count.

Take Your Investments to a Whole New Level